Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 3, 1998, Pages 353-356

  Reeves, Ronald K ^a   Stolp Smith, Kathryn A ^a   Christopherson, Mark W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CREATINE KINASE; DANTROLENE; DIAZEPAM; MIDAZOLAM; PROPOFOL;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG WITHDRAWAL; ENDOTRACHEAL INTUBATION; FEVER; HUMAN; HYPERTHERMIA; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; MALE; MALIGNANT HYPERTHERMIA; NASOGASTRIC TUBE; NEUROLEPTIC MALIGNANT SYNDROME; QUADRIPLEGIA; RHABDOMYOLYSIS; SPASTICITY;

EID: 0031957330     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90021-1     Document Type: Article

References (27)

1. Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226-32.
2. Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 1987;66:181-5.
3. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-21.
4. Penn RD, York NM, Paice JA. Catheter systems for intrathecal drug delivery. J Neurosurg 1995;83:215-17.
5. Concalves J, Garcia-March G, Sanchez-Ledesma MJ, Onzain I, Broseta J. Management of intractable spasticity of supraspinal origin by chronic cervical intrathecal infusion of baclofen. Stereotact Funct Neurosurg 1994;62:108-12.
6. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-7.
7. Rifici C, Kofler M, Kronenberg M, Kofler A, Bramanti P, Saltuari L. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol 1994;9:29-34.
8. Terrence CF, Fromm GH. Complications of baclofen withdrawal. Arch Neurol 1981;38:588-9.
9. Swigar ME, Bowers MB. Baclofen withdrawal and the neuropsychiatric symptoms: a case report and review of other case literature. Compr Psychiatry 1986;27:396-400.
10. Kofler M, Artuno Leis A. Prolonged seizure activity after baclofen withdrawal. Neurology 1992;42:697-8.
11. Mandac BR, Hurvitz EA, Nelson VS. Hyperthermia associated with baclofen withdrawal and increased spasticity. Arch Phys Med Rehabil 1993;74:96-7.
12. Siegfried RN, Jacobson L, Chabal C. Development of a acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. Anesthesiology 1992;77:1048-50.
13. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 1992;71:321-7.
14. Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesth Analg 1995;80:1054-6.
15. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2.
16. Schmidt K, Chan C. Thermoregulation and fever in normal persons and those with spinal cord injuries. Mayo Clin Proc 1992;67:469-75.
17. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185-202.
18. Velamoor VR, Norman RMG, Caroff SN, Mann SC, Sullivan KA, Antelo RE. Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994;182:168-73.
19. Heiman-Patterson TD. Neuroleptic malignant syndrome and malignant hyperthermia. Med Clin North Am 1993;77:477-92.
20. Daras M, Kakkouras L, Tuchman AJ, Koppel BS. Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? Acta Neurol Scand 1995;92:161-5.
21. Nisijima K, Ishiguro T. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acids in neuroleptic malignant syndrome. J Psychiatr Res 1995;29:233-44.
22. Di Rosa AE, Morgante L, Spina E, Meduri M. Epidemiology and pathoetiology of neurological syndromes with hyperthermia. Funct Neurol 1995;10:111-19.
23. B receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 1995;46:423-62.
24. B receptor site distribution in the rat central nervous system. Neuroscience 1987;20:365-85.
25. Meythaler JM. Intrathecal baclofen for spastic hypertonia in brain injury. J Head Trauma Rehabil 1997;12:87-90.
26. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: WB. Saunders Co; 1992.
27. Kroin JS, Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993;33:226-30.